Hin Yu Vincent Tu1, Armand Zini. 1. Division of Urology, Department of Surgery, McGill University, Montreal, Quebec, Canada.
Abstract
OBJECTIVE: To report a case of low-dose finasteride-induced secondary infertility with associated elevated sperm DNA fragmentation index (DFI) and otherwise normal semen parameters. DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 48-year-old man on low-dose finasteride and his 37-year-old wife with normal menses and normal gynecologic exam. INTERVENTION(S): Determination of sperm DFI and discontinuation of low-dose finasteride. MAIN OUTCOME MEASURE(S): Sperm DFI. RESULT(S): The sperm DFI done a year earlier was 30%. This value was unchanged when repeated 2 months later. The patient was advised to stop finasteride. Three months after discontinuing the finasteride, the DFI decreased to 21% and subsequent DFI after another 3 months improved to 16.5%. To date, there is still no documented full-term pregnancy or live birth. CONCLUSION(S): The significant reduction in DFI within 3 months of finasteride cessation and continued improvement suggests a causal link between finasteride and sperm DNA damage. We hypothesize that low-dose finasteride may exert a negative influence on sperm DNA integrity, resulting in increased pregnancy losses. We suggest that in infertile men using finasteride, sperm DFI should be measured in addition to semen parameters, and a trial of discontinuation of finasteride may be warranted.
OBJECTIVE: To report a case of low-dose finasteride-induced secondary infertility with associated elevated sperm DNA fragmentation index (DFI) and otherwise normal semen parameters. DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 48-year-old man on low-dose finasteride and his 37-year-old wife with normal menses and normal gynecologic exam. INTERVENTION(S): Determination of sperm DFI and discontinuation of low-dose finasteride. MAIN OUTCOME MEASURE(S): Sperm DFI. RESULT(S): The sperm DFI done a year earlier was 30%. This value was unchanged when repeated 2 months later. The patient was advised to stop finasteride. Three months after discontinuing the finasteride, the DFI decreased to 21% and subsequent DFI after another 3 months improved to 16.5%. To date, there is still no documented full-term pregnancy or live birth. CONCLUSION(S): The significant reduction in DFI within 3 months of finasteride cessation and continued improvement suggests a causal link between finasteride and sperm DNA damage. We hypothesize that low-dose finasteride may exert a negative influence on sperm DNA integrity, resulting in increased pregnancy losses. We suggest that in infertile men using finasteride, sperm DFI should be measured in addition to semen parameters, and a trial of discontinuation of finasteride may be warranted.
Authors: Ion G Motofei; David L Rowland; Mirela Manea; Simona R Georgescu; Ioana Păunică; Ioanel Sinescu Journal: Clin Drug Investig Date: 2017-06 Impact factor: 2.859
Authors: Kiran Kumar Soni; Yu Seob Shin; Bo Ram Choi; Keshab Kumar Karna; Hye Kyung Kim; Sung Won Lee; Chul Young Kim; Jong Kwan Park Journal: Drug Des Devel Ther Date: 2017-10-11 Impact factor: 4.162